Storing blood and tumor samples from people with skin cancer for research

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with malignant melanoma, or a past history of melanoma, and for healthy donors. Blood and tumor samples are collected and stored for future research.

Sex

All sexes can join.

Disease stage

Any stage of malignant melanoma.

Main reasons for not taking part

• Incarcerated individuals cannot join.

The registry criteria, word for word

What the trial wants to find out

This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.

The group in the trial

• Ancillary-correlative (biospecimen collection)

  Patients undergo collection of blood samples at the time of the initial diagnostic work-up, and possibly prior to the initiation of surgery, chemotherapy, immunotherapy, or radiation therapy, at tumor progression or recurrence, and annually during routine follow-up (no more than 4 blood draws per year). Patients may also undergo collection of tissue sample during standard of care surgical or radiologic procedures. Healthy individuals undergo collection of blood samples up to 4 times over 1 year.

  Treatment: Biospecimen Collection